Please login to the form below

Not currently logged in
Email:
Password:

Vetter

This page shows the latest Vetter news and features for those working in and with pharma, biotech and healthcare.

GSK files immune deficiency gene therapy in Europe

GSK files immune deficiency gene therapy in Europe

A variant of the genetic disorder is known as bubble boy disease, after SCID patient David Vetter who spent much of his short life in a sterile chamber and died as

Latest news

  • Inside out

    The Author. Donna Vetter is an independent consultant to the pharma industry.

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Vetter names Oliver Albrecht as managing director Vetter names Oliver Albrecht as managing director

    He has over 20 years of industry experience. Contract development and manufacturing organisation Vetter has appointed Oliver Albrecht as managing director, effective from April 1. ... compliance. Udo J Vetter, Vetter chairman of the advisory board,

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics